Mobilized CD34+ cells as a biomarker candidate for the efficacy of combined maximal tolerance dose and continuous infusional chemotherapy and G-CSF surge in gastric cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/18555590

Cancer Lett. 2008 Nov 8 270 2 269-76

Download in:

View as

General Info

PMID
18555590